CD4 and COVID-19: In a study by Karagiannis et al. [116], when human TH1 CD4 + lymphocytes obtained from patients with severe COVID-19 with BHB were cultured, an increase in CD4+ cells and IFNy production, and a decrease in PD-1 (programmed death receptor 1) expression were observed.